Recombinant Human DOCK2 Protein，His

DOCK2 (Dedicator of Cytokinesis 2) is a member of the DOCK family of proteins, which are known for their role as guanine nucleotide exchange factors (GEFs) that activate small GTPases. This signaling pathway is crucial for various cellular processes, including cell migration, adhesion, and the immune response. DOCK2 is predominantly expressed in hematopoietic cells and has gained extensive interest due to its involvement in lymphocyte function and development. Research has demonstrated that DOCK2 facilitates the activation of Rho GTPases, which are essential for cytoskeleton reorganization and cellular motility. Mutations or dysregulation of DOCK2 have been implicated in various immunological disorders and cancers, highlighting its potential as a therapeutic target. The study of recombinant DOCK2 proteins not only aids in understanding its structure-function relationship but also illuminates the molecular mechanisms underlying its role in signaling pathways. Researchers utilize recombinant protein techniques to produce DOCK2 for detailed biochemical and biophysical studies, enabling the exploration of its interactions with other cellular components. This research ultimately aims to delineate the functional roles of DOCK2 in health and disease, paving the way for the development of novel therapeutic strategies targeting this protein for immunological and oncological conditions.